Patents Assigned to Proteinex, Inc.
  • Patent number: 6306663
    Abstract: The invention relates to novel compounds comprising a ubiquitination recognition element and a protein binding element. The invention also relates to the use of said compounds for modulating the level and/or activity of a target protein. The compounds are useful for the treatment of disease such as infections, inflammatory conditions, cancer and genetic diseases. The compounds are also useful as insecticides and herbicides.
    Type: Grant
    Filed: September 28, 1999
    Date of Patent: October 23, 2001
    Assignee: Proteinex, Inc.
    Inventors: John H. Kenten, Steven F. Roberts